Geratherm Medical AG

GME · Healthcare

About Geratherm Medical AG (GME)

Geratherm Medical AG is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Geschwenda, Germany. GME has been publicly traded since 2000, giving it 26+ years of trading history.

Geratherm Medical AG (GME) has been publicly traded since 2000, making it a 26-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Geschwenda, Germany and employs approximately 144 people. With a market capitalization of €15 million, GME is a micro-cap company.

GME trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a micro-cap-cap stock with a market capitalization of approximately €15 million. The company employs approximately 144 people worldwide.

Sector
Healthcare
Industry
Medical Devices
Headquarters
Geschwenda, Germany
IPO Year
2000

Key Statistics

Current Price
€2.82
Market Cap
€15.26M
52-Week High
€7.88
52-Week Low
€2.48
Sector
Healthcare
Industry
Medical Devices

GME Investment Performance

GME has declined 2.4% year-to-date in 2026. Over the past 5 years, a €1,000 investment in GME would have grown to €268, representing a -73.2% total return. Since its IPO in 2000, a €1,000 investment would now be worth €675.

€1,000 Invested in Geratherm Medical AG (GME)

1 Year
€892
+-11%
3 Years
€397
+-60%
5 Years
€268
+-73%
10 Years
€336
+-66%
Since IPO
€675
+-33%

How much would €1,000 invested in GME be worth today?

What would €1,000 invested in GME 1 year ago be worth today?

A €1,000 investment in Geratherm Medical AG (GME) in 2025 would be worth €892 as of March 2026, representing a -10.8% total return.

What would €1,000 invested in GME 3 years ago be worth today?

A €1,000 investment in Geratherm Medical AG (GME) in 2023 would be worth €397 as of March 2026, representing a -60.3% total return.

What would €1,000 invested in GME 5 years ago be worth today?

A €1,000 investment in Geratherm Medical AG (GME) in 2021 would be worth €268 as of March 2026, representing a -73.2% total return.

What would €1,000 invested in GME 10 years ago be worth today?

A €1,000 investment in Geratherm Medical AG (GME) in 2016 would be worth €336 as of March 2026, representing a -66.4% total return.

What would €1,000 invested in GME at IPO be worth today?

A €1,000 investment in Geratherm Medical AG (GME) at IPO would be worth €675 as of March 2026, representing a -32.5% total return.

Monthly Returns Heatmap

Avg Monthly Return
+0.35%
Positive Months
145
47% of 308
Negative Months
152
49% of 308
Data Period
25+ years
308 months
Best Performers
Best month ever: Nov 2024 (+58.4%)
Best month on avg: May (+4.2%)
Worst Performers
Worst month ever: Dec 2024 (-31.4%)
Worst month on avg: September (-3.2%)

Over the past 25+ years (308 months), Geratherm Medical AG (GME) has averaged a monthly return of +0.35% with a median return of +0.00%. The stock had 145 positive months (47%) and 152 negative months (49%). The best month in GME's history was November 2024 with a +58.4% return, while the worst was December 2024 at -31.4%. Historically, May tends to be the strongest month (averaging +4.2%), and September the weakest (-3.2%).

GME's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 9 consecutive months of losses. The best full year was 2009 with a cumulative return of +86.1%, and the worst was 2008 at -49.7%.

Annual Returns

Over 26 years of trading history, Geratherm Medical AG (GME) has delivered an average annual return of +3.95% with a median return of +2.31%. The compound annual growth rate (CAGR) is -1.44%. The stock posted gains in 14 years (54%) and losses in 12 years (46%).

GME's best year was 2009 with a +113.55% gain, while the worst was 2001 at -45.55%. The longest streak of consecutive positive years was 5, and the longest losing streak was 3 years. GME achieved double-digit gains (10%+) in 10 years. It suffered double-digit losses in 9 years.

Avg Return
+3.95%
Best Year
2009 (+113.55%)
Worst Year
2001 (-45.55%)
Positive Years
14/26
Year Return Start End
2026 -2.42% €2.89 €2.82
2025 -14.88% €3.40 €2.89
2024 -33.49% €5.10 €3.40
2023 +10.66% €4.61 €5.10
2022 -39.47% €7.62 €4.61
2021 -20.31% €9.56 €7.62
2020 +31.30% €7.28 €9.56
2019 +0.18% €7.27 €7.28
2018 -23.80% €9.54 €7.27
2017 +6.88% €8.93 €9.54
2016 +12.34% €7.95 €8.93
2015 +33.42% €5.96 €7.95
2014 +20.74% €4.93 €5.96
2013 +44.21% €3.42 €4.93
2012 -17.13% €4.13 €3.42
2011 -5.97% €4.39 €4.13
2010 +14.74% €3.83 €4.39
2009 +113.55% €1.79 €3.83
2008 -41.31% €3.05 €1.79
2007 +4.44% €2.92 €3.05
2006 +7.65% €2.72 €2.92
2005 -7.03% €2.92 €2.72
2004 +43.48% €2.04 €2.92
2003 +50.00% €1.36 €2.04
2002 -39.42% €2.24 €1.36
2001 -45.55% €4.11 €2.24

GME Investment Analysis: Valuation, Risk & Dividends

Key factors to consider when evaluating Geratherm Medical AG as an investment

Valuation

GME currently trades at a trailing P/E ratio of 8.1, which is considered low relative to the broader market. The forward P/E of 47.0 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 0.7. The price-to-sales ratio is 1.1.

Dividends

Geratherm Medical AG pays a dividend to shareholders with a current yield of 3.55%. This translates to €0.10 per share annually. The payout ratio of 28% indicates sustainable dividend coverage.

Risk & Volatility

GME has a beta of 0.53, indicating it is less volatile than the overall market. The stock's 52-week range is €2.48 to €7.88, and it currently trades near its 52-week low.

Analyst Ratings

Based on 1 analyst opinion, GME has a consensus "none" rating. The average price target of €6.00 suggests 112.8% upside from current levels.

Frequently Asked Questions: GME

What sector is GME in?

GME operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.

How has GME performed historically?

Over 26 years of trading history, GME has posted gains in 14 years (54% of the time). The best year was 2009 with a +113.5% return. Past performance does not guarantee future results.

How can I invest in GME?

You can invest in GME through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold GME.

Does GME pay dividends?

Geratherm Medical AG pays a dividend to shareholders with a current yield of 3.55%. This translates to €0.10 per share annually. The payout ratio of 28% indicates sustainable dividend coverage.

What does Geratherm Medical AG do?

Geratherm Medical AG is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Geschwenda, Germany.

What sector is GME in?

GME operates in the Healthcare sector, specifically in the Medical Devices industry.

When did GME go public?

Geratherm Medical AG went public in 2000, making it a 26-year-old public company as of 2026.

How much would €1,000 invested in GME 5 years ago be worth today?

A €1,000 investment in GME five years ago would be worth approximately €268 today, representing a -73.2% return.

How much would €1,000 invested in GME 10 years ago be worth today?

A €1,000 investment in GME ten years ago would be worth approximately €336 today, representing a -66.4% total return over the decade.

What is GME's 3-year return?

Over the past 3 years, GME has returned -60.3%. A €1,000 investment would have grown to €397.

How much would €1,000 invested in GME at IPO be worth today?

If you invested €1,000 in GME at its IPO in 2000, it would be worth approximately €675 today, a -32.5% return over 26 years.

Does GME pay dividends?

Yes, Geratherm Medical AG pays a dividend with a current yield of 3.55%, which is €0.1 per share annually.

What is GME's market cap?

Geratherm Medical AG has a market capitalization of €15 million, classifying it as a micro-cap company.

What is GME's P/E ratio?

GME has a trailing P/E ratio of 8.1 and a forward P/E of 47.0, which measures how much investors are paying per dollar of earnings.

Is GME a buy, hold, or sell?

Based on 1 opinion, GME has a consensus "none" rating. The average price target is €6.0.

Last updated: 3/15/2026